Peds
Severe Congenital Neutropenia
search
Severe Congenital Neutropenia
See Also
Neutropenia
Neutropenia Causes
Epidemiology
Incidence
: 10-15 cases per 1 million live births
Age of diagnosis as infant or young child
Findings
Failure to Thrive
Recurrent infections involving the skin and mucous membranes
Often severe, life-threatening
Labs
Complete Blood Count
Severe
Neutropenia
(ANC <500/uL)
Associated Conditions
Hematologic Malignancy
(10-40% lifetime risk)
Myelodysplasia
Acute Myelogenous Leukemia
Conditions with skeletal abnormalities
Organomegaly Syndromes
Wiskott-Aldrich Syndrome
Kostman Syndrome
Shwachman-Diamond Syndrome
Management
Gene
ral prevention of infections
Good hygiene practices
Lifestyle modifications to reduce infection risk
Granulocyte Colony Stimulating Factor
(
G-CSF
)
Filgrastim
(
Neupogen
)
Pegfilgrastim
(
Neulasta
)
Sargramostim
Consider
Hematopoietic Stem Cell Transplant
(
HSCT
)
Surveillance for
Hematologic Malignancy
Antibiotic
Prophylaxis
Indications: Primary
Antibiotic
prophylaxis
High risk patients
Includes patients with >=20% risk of
Febrile Neutropenia
Indications: Secondary
Antibiotic
prophylaxis
Neutropenic complications from prior
Chemotherapy
High risk for
Febrile Neutropenia
Severe prolonged
Neutropenia
(ANC <100 uL for >=7 days)
Prophylaxis protocol
Fluoroquinolone
(e.g.
Levofloxacin
) AND
Antifungal
(select one)
Oral
Triazole Antifungal
(e.g.
Fluconazole
,
Itraconazole
, and
Voriconazole
)
IV
Echinocandin
(e.g.
Caspofungin
,
Micafungin
)
References
Kim (2025) Am Fam Physician 112(6): 618-28 [PubMed]
Type your search phrase here